FIELD: pharmacology.
SUBSTANCE: group of inventions refers to medicine, namely, to transplantology and immunology, and can be used to prepare a pharmaceutical composition for treatment of the graft-versus-host reaction. A pharmaceutical composition for graft-versus-host reaction treatment comprising an anti-CCL8 antibody as an active ingredient. The group of inventions also relates to a method of graft-versus-host reaction treatment comprising anti-CCL8 antibody administration to a subject.
EFFECT: use of this group of inventions provides prevention of organ damage in patients with GVHD with the use of CCL8 antibodies.
2 cl, 9 ex, 17 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING OR TREATING GRAFT VERSUS HOST REACTION | 2008 |
|
RU2479846C2 |
| ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN TRANSPLANTATION AND DISEASE TREATMENT | 2009 |
|
RU2506311C2 |
| HUMANISED ANTI-TAU ANTIBODIES | 2015 |
|
RU2743152C2 |
| 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE-METHYL, POLYMORPHOUS FORMS AND METHODS FOR USE THEREOF | 2014 |
|
RU2693833C2 |
| SUBSTANCES AND METHODS OF TREATING MULTIPLE SCLEROSIS MEDIATED BY B CELLS | 2009 |
|
RU2522251C2 |
| ANTIBODIES FIGHTING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND THEIR APPLICATION | 2003 |
|
RU2339647C2 |
| MEANS AND METHODS FOR DIAGNOSING AND TREATING MULTIPLE SCLEROSIS | 2012 |
|
RU2601298C2 |
| NOVEL TUMOUR BIOMARKER | 2010 |
|
RU2567005C2 |
| TROPOMYOSIN ISOFORMS RELATED TO ALZHEIMER'S DISEASE AND MODERATE COGNITIVE IMPAIRMENTS | 2013 |
|
RU2661022C2 |
| SYPHILIS DIAGNOSTIC TECHNIQUE WITH USING METHOD OF DIRECT PROTEOMIC BLOOD SERUM PROFILING | 2008 |
|
RU2381505C1 |
